skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Simple Search

Results 1 - 20 of 187,215  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Material Type:
Article 		Add to My Research

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

BMC cancer, 2021-09, Vol.21 (1), p.1-1045, Article 1045 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08766-9 ;PMID: 34556087

Full text available

Citations Cited by
2
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Material Type:
Article 		Add to My Research

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature

PloS one, 2012-12, Vol.7 (12), p.e50946-e50946 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Zhang et al 2012 Zhang et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0050946 ;PMID: 23284651

Full text available

Citations Cited by
3
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Material Type:
Article 		Add to My Research

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

PloS one, 2013-08, Vol.8 (8), p.e71583 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Franciosi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Franciosi et al 2013 Franciosi et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0071583 ;PMID: 23936520

Full text available

Citations Cited by
4
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Material Type:
Article 		Add to My Research

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5675-4 ;PMID: 31126258

Full text available

Citations Cited by
5
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Material Type:
Article 		Add to My Research

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482

Full text available

Citations Cited by
6
Classification of circulating tumor cells by epithelial-mesenchymal transition markers
Classification of circulating tumor cells by epithelial-mesenchymal transition markers
Material Type:
Article 		Add to My Research

Classification of circulating tumor cells by epithelial-mesenchymal transition markers

PloS one, 2015-04, Vol.10 (4), p.e0123976-e0123976 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Wu et al 2015 Wu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0123976 ;PMID: 25909322

Full text available

Citations Cited by
7
Plasma free amino acid profiling of five types of cancer patients and its application for early detection
Plasma free amino acid profiling of five types of cancer patients and its application for early detection
Material Type:
Article 		Add to My Research

Plasma free amino acid profiling of five types of cancer patients and its application for early detection

PloS one, 2011-09, Vol.6 (9), p.e24143-e24143 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Miyagi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Miyagi et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0024143 ;PMID: 21915291

Full text available

Citations Cited by
8
Chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe
Chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe
Material Type:
Article 		Add to My Research

Chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe

PloS one, 2022-06, Vol.17 (6), p.e0265930-e0265930 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Ciorcan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Ciorcan et al 2022 Ciorcan et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0265930 ;PMID: 35679539

Full text available

Citations Cited by
9
Portrait of a cancer: mutational signature analyses for cancer diagnostics
Portrait of a cancer: mutational signature analyses for cancer diagnostics
Material Type:
Article 		Add to My Research

Portrait of a cancer: mutational signature analyses for cancer diagnostics

BMC cancer, 2019-05, Vol.19 (1), p.457-457, Article 457 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5677-2 ;PMID: 31092228

Full text available

Citations Cited by
10
Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis
Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis
Material Type:
Article 		Add to My Research

Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis

BMC cancer, 2020-07, Vol.20 (1), p.662-662, Article 662 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07149-w ;PMID: 32677912

Full text available

Citations Cited by
11
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Material Type:
Article 		Add to My Research

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance

Molecular cancer, 2020-05, Vol.19 (1), p.96-96, Article 96 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-020-01219-0 ;PMID: 32460771

Full text available

Citations Cited by
12
Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer
Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer
Material Type:
Article 		Add to My Research

Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer

BMC cancer, 2019-12, Vol.19 (1), p.1230-1230, Article 1230 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6441-3 ;PMID: 31849319

Full text available

Citations Cited by
13
BMI-1, a promising therapeutic target for human cancer
BMI-1, a promising therapeutic target for human cancer
Material Type:
Article 		Add to My Research

BMI-1, a promising therapeutic target for human cancer

Oncology letters, 2015-08, Vol.10 (2), p.583-588 [Peer Reviewed Journal]

Copyright © 2015, Spandidos Publications ;COPYRIGHT 2015 Spandidos Publications ;COPYRIGHT 2015 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2015 ;Copyright © 2015, Spandidos Publications 2015 ;ISSN: 1792-1074 ;EISSN: 1792-1082 ;DOI: 10.3892/ol.2015.3361 ;PMID: 26622537

Full text available

Citations Cited by
14
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Material Type:
Article 		Add to My Research

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Nature genetics, 2019-02, Vol.51 (2), p.202-206 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Feb 2019 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-018-0312-8 ;PMID: 30643254

Full text available

Citations Cited by
15
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Material Type:
Article 		Add to My Research

Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis

Molecular cancer, 2019-03, Vol.18 (1), p.64-64, Article 64 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0976-4 ;PMID: 30927925

Full text available

Citations Cited by
16
No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study
No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study
Material Type:
Article 		Add to My Research

No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study

European journal of cancer (1990), 2019-07, Vol.116, p.169 [Peer Reviewed Journal]

ISSN: 0959-8049 ;ISSN: 1879-0852 ;EISSN: 1879-0852 ;DOI: 10.1016/j.ejca.2019.05.016

Digital Resources/Online E-Resources

Citations Cited by
17
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Material Type:
Article 		Add to My Research

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

The Journal of clinical investigation, 2019-03, Vol.129 (3), p.1211-1228 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Mar 2019 ;Copyright © 2019, American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci123319 ;PMID: 30589644

Full text available

Citations Cited by
18
Emerging organoid models: leaping forward in cancer research
Emerging organoid models: leaping forward in cancer research
Material Type:
Article 		Add to My Research

Emerging organoid models: leaping forward in cancer research

Journal of hematology and oncology, 2019-12, Vol.12 (1), p.142-142, Article 142 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0832-4 ;PMID: 31884964

Full text available

Citations Cited by
19
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p
Material Type:
Article 		Add to My Research

Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p

Molecular cancer, 2017-07, Vol.16 (1), p.132-14, Article 132 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-017-0694-8 ;PMID: 28743280

Full text available

Citations Cited by
20
POS0942 THE SIGNIFICANCE OF PRE-SCREENING OF SUBCLINICAL MALIGNANCIES BEFORE THE TREATMENT OF BIOLOGIC AGENTS OR JAK INHIBITORS TO CONNECTIVE TISSUE DISEASE PATIENTS
POS0942 THE SIGNIFICANCE OF PRE-SCREENING OF SUBCLINICAL MALIGNANCIES BEFORE THE TREATMENT OF BIOLOGIC AGENTS OR JAK INHIBITORS TO CONNECTIVE TISSUE DISEASE PATIENTS
Material Type:
Article 		Add to My Research

POS0942 THE SIGNIFICANCE OF PRE-SCREENING OF SUBCLINICAL MALIGNANCIES BEFORE THE TREATMENT OF BIOLOGIC AGENTS OR JAK INHIBITORS TO CONNECTIVE TISSUE DISEASE PATIENTS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.783-783 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.4307

Full text available

Citations Cited by

Results 1 - 20 of 187,215  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (166,862)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1965  (38)
  2. 1965 To 1979  (153)
  3. 1980 To 1994  (1,805)
  4. 1995 To 2010  (14,946)
  5. After 2010  (170,359)
  6. More options open sub menu

Subject 

  1. Science & Technology  (149,115)
  2. Life Sciences & Biomedicine  (134,268)
  3. Humans  (80,365)
  4. Cancer  (78,898)
  5. Oncology  (75,885)
  6. Tumors  (66,401)
  7. Cancer Therapies  (64,710)
  8. Chemotherapy  (52,272)
  9. Metastasis  (50,412)
  10. Medical Prognosis  (48,071)
  11. Female  (45,419)
  12. Surgery  (41,164)
  13. Male  (38,386)
  14. Middle Aged  (35,528)
  15. Care And Treatment  (32,024)
  16. Aged  (30,728)
  17. Breast Cancer  (29,378)
  18. Radiation Therapy  (27,510)
  19. Prognosis  (26,719)
  20. More options open sub menu

Language 

  1. English  (186,351)
  2. Japanese  (14,429)
  3. Chinese  (529)
  4. Turkish  (488)
  5. Portuguese  (285)
  6. French  (272)
  7. Norwegian  (240)
  8. Spanish  (137)
  9. German  (78)
  10. Polish  (51)
  11. Romanian  (19)
  12. Italian  (14)
  13. Russian  (13)
  14. Korean  (11)
  15. Dutch  (10)
  16. Catalan  (6)
  17. Slovenian  (6)
  18. Persian  (6)
  19. Arabic  (5)
  20. Afrikaans  (5)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait